Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®
Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®
Active, not recruiting · NCT04896853 · Registry updated 2025-05-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans® | COVID-19 Acute Respiratory Distress Syndrome; Influenza A; Metapneumovirus Pneumonia; Respiratory Syncytial Virus (RSV) | Active, not recruiting | Phase 1 | 2025-05-14 | NCT04896853 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Karolinska Trial Alliance | 4 |
| NextCell Pharma Ab | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Cardiology, Respiratory medicine and Physiology, Örebro University Hospital | Örebro | Sweden | 1 |